Results 91 to 100 of about 267 (125)

Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. [PDF]

open access: yesJ Enzyme Inhib Med Chem
Alasmary FAS   +6 more
europepmc   +1 more source

Serotypes and antimicrobial susceptibility of Salmonella spp. isolated from farm animals in China. [PDF]

open access: yesFront Microbiol, 2015
Kuang X   +6 more
europepmc   +1 more source

A Study of Resistome in Mexican Chili Powder as a Public Health Risk Factor. [PDF]

open access: yesAntibiotics (Basel)
Mena Navarro MP   +14 more
europepmc   +1 more source

Identification of Eight in vivo Metabolites of Mequindox in Scophthalmus maximus by using UHPLC-MS/MS

open access: yesFood Science and Human Wellness
Xin Mao   +7 more
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Metabolism of mequindox in liver microsomes of rats, chicken and pigs

Rapid Communications in Mass Spectrometry, 2010
Abstract Mequindox, 3‐methyl‐2‐quinoxalinacetyl‐1,4‐dioxide, is a quinoxaline‐ N , N ‐dioxide used in veterinary medicine as a antibacterial in China.
Zhao-Ying, Liu   +3 more
openaire   +4 more sources

Genotoxicity evaluation of Mequindox in different short-term tests

Food and Chemical Toxicology, 2013
Quinoxaline-1,4-dioxides (QdNOs) are the potent heterocyclic N-oxides with interesting biological properties such as antibacterial, anticandida, antitubercular, anticancer and antiprotozoal activities. Here, we tested and compared the mequindox (MEQ) for mutagenic abilities in a battery of different short term tests according to OECD guidelines.
Awais, Ihsan   +12 more
openaire   +2 more sources

Dynamic Metabolic Response of Mice to Acute Mequindox Exposure

Journal of Proteome Research, 2011
Mequindox is used as a veterinary antibiotic drug. As part of systematic investigations into mequindox as a veterinary medicine and its subsequent applications in food safety, we conducted the investigation to assess the metabolic response of mice to mequindox using metabonomics, which combines NMR metabolic profiles of biofluids or tissues and pattern
Xiu-Ju, Zhao   +5 more
openaire   +2 more sources

Acute and subchronic toxicological evaluation of Mequindox in Wistar rats

Regulatory Toxicology and Pharmacology, 2010
We studied an acute and subchronic oral toxicity of Mequindox (MEQ), a quinoxaline 1,4-dioxide antimicrobial promoter, in Wistar rats according to OECD guidelines. For acute toxicity study, single doses of MEQ at 175, 550 and 2000 mg/kg b.w. were administered to rats by oral gavage. The calculated LD(50) was 550 mg/kg b.w.
Awais, Ihsan   +6 more
openaire   +2 more sources

Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability

Colloids and Surfaces B: Biointerfaces, 2020
Mequindox (Meq) is a promising broad-spectrum antibacterial agent, but the clinical application of Meq has been hampered by its low oral bioavailability. Casein (Cas) can bind to a variety of poorly water-soluble drugs to improve their water solubility through a micellar solubilization mechanism. Here, a low-cost and convenient method was introduced to
Li, Chen   +13 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy